Jeanne Stuckey

6PUBLICATIONS
42CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomedical instrumentationBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 10, 2024
Second-Generation Cap Analogue Prodrugs for Targeting Aberrant Eukaryotic Translation Initiation Factor 4E (eIF4E) Activity in Drug-Resistant Melanoma.

Emilio L Cárdenas, Rachel L O'Rourke, Arya Menon

|Jun 09, 2023
Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer.

Emilio L Cárdenas, Rachel L O'Rourke, Arya Menon

|Feb 02, 2023
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo.

Atsunori Kaneshige, Longchuan Bai, Mi Wang

|Sep 01, 2022
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy.

Jing Deng, Aneel Paulus, Douglas D Fang

|Mar 13, 2019
How Outer Coordination Sphere Modifications Can Impact Metal Structures in Proteins: A Crystallographic Evaluation.

Leela Ruckthong, Jeanne A Stuckey, Vincent L Pecoraro

Pageof 1